PMID- 33053761 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201103 IS - 2076-3921 (Print) IS - 2076-3921 (Electronic) IS - 2076-3921 (Linking) VI - 9 IP - 10 DP - 2020 Oct 12 TI - Protective Effect of Geraniol on Oxidative, Inflammatory and Apoptotic Alterations in Isoproterenol-Induced Cardiotoxicity: Role of the Keap1/Nrf2/HO-1 and PI3K/Akt/mTOR Pathways. LID - 10.3390/antiox9100977 [doi] LID - 977 AB - BACKGROUND: Myocardial infarction (MI) is still a major contributor to mortality worldwide, and therefore, searching for new drugs is an urgent priority. Natural products are a renewable source for medicinally and pharmacologically active molecules. The objective of this study was to explore the potential of geraniol, a monoterpene alcohol, to protect against MI. METHODS: Five groups of Wister rats were used: a control group; a group treated only with geraniol; a group treated only with isoproterenol, to induce MI; and two groups pretreated with geraniol (100 or 200 mg/kg, respectively) for 14 days and challenged with isoproterenol on the 13th and 14th days. Several parameters were measured including electrocardiogram (ECG), cardiac markers, the expression of Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-related factor 2 (Nrf2), and other downstream antioxidant enzymes, as well as the expression of phosphoinositide 3-kinases (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) and other downstream apoptotic and inflammatory mediators. RESULTS: Geraniol treatment reduced the size of the infarct region, attenuated the levels of cardiac indicators, and diminished myocardial necrosis and immune cell infiltration. Geraniol treatment also activated the Keap1/Nrf2/heme oxygenase-1 (HO-1) pathway, increased antioxidant enzyme activities, modulated the PI3K/Akt/mTOR pathway, and ameliorated myocardial autophagy, inflammation, and apoptosis. CONCLUSION: Geraniol may possess a protective effect against MI through moderating MI-induced myocardial oxidative stress (glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione S-transferase (GST), and Keap1/Nrf2 pathway), inflammation (IL-1beta, IL-6, TNF-alpha, and Nuclear factor-kappaB (NF-kappaB)), apoptosis (caspase-3, caspase-9, Bcl2, and Bax), and autophagy (PI3K/Akt/mTOR pathway). FAU - Younis, Nancy S AU - Younis NS AUID- ORCID: 0000-0003-4309-7095 AD - Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, 31982 Al-Ahsa, Saudi Arabia. AD - Pharmacology Department, Zagazig University, Zagazig 44519, Egypt. FAU - Abduldaium, Mohamed S AU - Abduldaium MS AD - Department of Cardiology, College of Medicine, Zagazig University, Zagazig 44519, Egypt. FAU - Mohamed, Maged E AU - Mohamed ME AUID- ORCID: 0000-0002-1216-8703 AD - Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, 31982 Al-Ahsa, Saudi Arabia. AD - Department of Pharmacognosy, College of Pharmacy, Zagazig University, Zagazig 44519, Egypt. LA - eng GR - IFT20016/Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia/ PT - Journal Article DEP - 20201012 PL - Switzerland TA - Antioxidants (Basel) JT - Antioxidants (Basel, Switzerland) JID - 101668981 PMC - PMC7599734 OTO - NOTNLM OT - apoptosis OT - autophagy OT - essential oil OT - inflammatory mediators OT - monoterpenes OT - oxidative stress COIS- The authors declare no conflict of interest. EDAT- 2020/10/16 06:00 MHDA- 2020/10/16 06:01 PMCR- 2020/10/12 CRDT- 2020/10/15 01:01 PHST- 2020/08/18 00:00 [received] PHST- 2020/09/25 00:00 [revised] PHST- 2020/10/10 00:00 [accepted] PHST- 2020/10/15 01:01 [entrez] PHST- 2020/10/16 06:00 [pubmed] PHST- 2020/10/16 06:01 [medline] PHST- 2020/10/12 00:00 [pmc-release] AID - antiox9100977 [pii] AID - antioxidants-09-00977 [pii] AID - 10.3390/antiox9100977 [doi] PST - epublish SO - Antioxidants (Basel). 2020 Oct 12;9(10):977. doi: 10.3390/antiox9100977.